Deciphera Pharmaceuticals (DCPH) Income Statement (2017 - 2024)
Income Statement report data from Sep 30, 2017 to Mar 31, 2024 for Deciphera Pharmaceuticals (DCPH).
Reported currency: USD
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||
Total Revenue | 45M (-6.81%) | 48M (+11.50%) | 43M (+13.08%) | 38M (+14.50%) | 33M (-7.98%) | 36M (+1.06%) | 36M (+10.71%) | 32M (+11.19%) | 29M (+20.74%) | 24M (+4.22%) | 23M (-1.48%) | 24M (-6.32%) | 25M (+29.09%) | 19M (+26.15%) | 15M (+117.91%) | 7.09M (+11716.67%) | 60K | - | - | 25M | - | - | - | - | - | - | - |
Cost Of Revenue | 2.09M (+16.76%) | 1.79M (+38.76%) | 1.29M (+658.82%) | 170K (-65.31%) | 490K (-84.92%) | 3.25M (-2.69%) | 3.34M (+85.56%) | 1.80M (+373.68%) | 380K (-26.92%) | 520K (-43.48%) | 920K (-27.56%) | 1.27M (+477.27%) | 220K (+69.23%) | 130K (+44.44%) | 90K (+800.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | 2.09M (+16.76%) | 1.79M (+38.76%) | 1.29M (+658.82%) | 170K (-65.31%) | 490K (-84.92%) | 3.25M (-2.69%) | 3.34M (+85.56%) | 1.80M (+373.68%) | 380K (-26.92%) | 520K (-43.48%) | 920K (-27.56%) | 1.27M (+477.27%) | 220K (+69.23%) | 130K (+44.44%) | 90K (+800.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 43M (-7.74%) | 47M (+10.66%) | 42M (+10.23%) | 38M (+15.69%) | 33M (-0.42%) | 33M (+1.44%) | 33M (+6.29%) | 31M (+6.45%) | 29M (+21.79%) | 24M (+6.19%) | 22M (0.00%) | 22M (-10.55%) | 25M (+28.77%) | 19M (+26.04%) | 15M (+116.95%) | 7.08M (+11700.00%) | 60K | - | - | 25M | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||
Research And Development | 58M (-1.31%) | 59M (-6.18%) | 62M (+7.14%) | 58M (+6.45%) | 55M (+13.94%) | 48M (+1.22%) | 47M (+5.86%) | 45M (-5.38%) | 47M (-36.73%) | 75M (+12.78%) | 66M (+10.77%) | 60M (+7.72%) | 56M (+6.48%) | 52M (+6.26%) | 49M (+6.79%) | 46M (-10.33%) | 51M (+10.18%) | 47M (+15.53%) | 40M (+15.97%) | 35M (-2.74%) | 36M (+30.81%) | 27M (+32.62%) | 21M (+14.74%) | 18M (+6.20%) | 17M (+8.11%) | 16M (+60.62%) | 9.75M |
Selling General And Administrative | 34M (-13.36%) | 39M (+17.74%) | 33M (+1.96%) | 33M (+3.69%) | 31M (-2.33%) | 32M (+7.23%) | 30M (+1.35%) | 30M (+4.63%) | 28M (-23.77%) | 37M (+4.56%) | 36M (+8.22%) | 33M (+6.76%) | 31M (+2.26%) | 30M (-0.23%) | 30M (+0.70%) | 30M (+25.02%) | 24M (+0.84%) | 24M (+32.04%) | 18M (+36.63%) | 13M (-0.60%) | 13M (+104.64%) | 6.47M (+23.00%) | 5.26M (+18.20%) | 4.45M (-11.53%) | 5.03M (+7.48%) | 4.68M (+92.59%) | 2.43M |
Operating Expenses | 92M (-6.13%) | 98M (+2.12%) | 96M (+5.29%) | 91M (+5.45%) | 86M (+7.41%) | 80M (+3.55%) | 78M (+4.07%) | 74M (-1.65%) | 76M (-32.43%) | 112M (+9.91%) | 102M (+9.87%) | 93M (+7.38%) | 86M (+4.94%) | 82M (+3.78%) | 79M (+4.41%) | 76M (+0.92%) | 75M (+7.03%) | 70M (+20.60%) | 58M (+21.61%) | 48M (-2.14%) | 49M (+44.93%) | 34M (+30.67%) | 26M (+15.43%) | 22M (+2.19%) | 22M (+7.92%) | 20M (+67.00%) | 12M |
Operating Income | |||||||||||||||||||||||||||
Operating Income | -48.85M (-4.66%) | -51.24M (-4.56%) | -53.69M (+1.74%) | -52.77M (-0.92%) | -53.26M (+12.93%) | -47.16M (+5.08%) | -44.88M (+2.49%) | -43.79M (-6.61%) | -46.89M (-46.96%) | -88.40M (+10.96%) | -79.67M (+12.99%) | -70.51M (+14.67%) | -61.49M (-2.40%) | -63.00M (-1.56%) | -64.00M (-7.15%) | -68.93M (-8.41%) | -75.26M (+6.95%) | -70.37M (+20.60%) | -58.35M (+154.03%) | -22.97M (-53.14%) | -49.02M (+44.90%) | -33.83M (+30.67%) | -25.89M (+15.43%) | -22.43M (+2.19%) | -21.95M (+7.92%) | -20.34M (+67.00%) | -12.18M |
EBITDA | -48.40M (-10.57%) | -54.12M (+8.50%) | -49.88M (-5.48%) | -52.77M (+0.23%) | -52.65M (+6.17%) | -49.59M (+20.66%) | -41.10M (-4.35%) | -42.97M (-6.81%) | -46.11M (-47.38%) | -87.62M (+11.04%) | -78.91M (+13.10%) | -69.77M (+14.83%) | -60.76M (-2.47%) | -62.30M (-1.63%) | -63.33M (-7.48%) | -68.45M (-8.49%) | -74.80M (+6.96%) | -69.93M (+20.20%) | -58.18M (+154.51%) | -22.86M (-53.27%) | -48.92M (+45.03%) | -33.73M (+30.74%) | -25.80M (+15.44%) | -22.35M (+2.10%) | -21.89M (+7.89%) | -20.29M (+67.13%) | -12.14M |
Other Income / Expenses | |||||||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K (-50.00%) | -20.00K (0.00%) | -20.00K (+100.00%) | -10.00K (-50.00%) | -20.00K (0.00%) | -20.00K (0.00%) | -20.00K (0.00%) | -20.00K (0.00%) | -20.00K (0.00%) | -20.00K |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K (-50.00%) | 20K (-33.33%) | 30K (+200.00%) | 10K (-50.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K |
Other Non Operating Income | 3.76M (-16.07%) | 4.48M (+9.00%) | 4.11M (-2.38%) | 4.21M (+15.34%) | 3.65M (+87.18%) | 1.95M (+5.98%) | 1.84M (+152.05%) | 730K | - | 10K | -170.00K | 80K (-60.00%) | 200K (-23.08%) | 260K (-13.33%) | 300K (-82.25%) | 1.69M (-31.30%) | 2.46M (-22.40%) | 3.17M (+46.08%) | 2.17M (+40.91%) | 1.54M (-6.67%) | 1.65M (+6.45%) | 1.55M (+4.73%) | 1.48M (+94.74%) | 760K (+40.74%) | 540K (+20.00%) | 450K (+164.71%) | 170K |
Net Income | |||||||||||||||||||||||||||
Income Before Tax | -45.08M (-3.59%) | -46.76M (-5.69%) | -49.58M (+2.10%) | -48.56M (-2.12%) | -49.61M (+9.73%) | -45.21M (+5.04%) | -43.04M (-0.05%) | -43.06M (-8.17%) | -46.89M (-46.95%) | -88.39M (+10.71%) | -79.84M (+13.36%) | -70.43M (+14.89%) | -61.30M (-2.30%) | -62.74M (-1.51%) | -63.70M (-5.26%) | -67.24M (-7.65%) | -72.81M (+8.32%) | -67.22M (+19.61%) | -56.20M (+161.88%) | -21.46M (-54.71%) | -47.38M (+46.69%) | -32.30M (+32.21%) | -24.43M (+12.63%) | -21.69M (+1.21%) | -21.43M (+7.63%) | -19.91M (+65.37%) | -12.04M |
Income Tax Expense | - | 430K | - | - | - | 720K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -45.08M (-4.47%) | -47.19M (-4.82%) | -49.58M (+2.10%) | -48.56M (-2.12%) | -49.61M (+8.01%) | -45.93M (+6.71%) | -43.04M (-0.05%) | -43.06M (-8.17%) | -46.89M (-46.95%) | -88.39M (+10.71%) | -79.84M (+13.36%) | -70.43M (+14.89%) | -61.30M (-2.30%) | -62.74M (-1.51%) | -63.70M (-5.26%) | -67.24M (-7.65%) | -72.81M (+8.32%) | -67.22M (+19.61%) | -56.20M (+161.88%) | -21.46M (-54.71%) | -47.38M (+46.69%) | -32.30M (+32.21%) | -24.43M (+12.63%) | -21.69M (+1.21%) | -21.43M (+7.63%) | -19.91M (+65.37%) | -12.04M |
Net Income | -45.08M (-4.47%) | -47.19M (-4.82%) | -49.58M (+2.10%) | -48.56M (-2.12%) | -49.61M (+8.01%) | -45.93M (+6.71%) | -43.04M (-0.05%) | -43.06M (-8.17%) | -46.89M (-46.95%) | -88.39M (+10.71%) | -79.84M (+13.36%) | -70.43M (+14.89%) | -61.30M (-2.30%) | -62.74M (-1.51%) | -63.70M (-5.26%) | -67.24M (-7.65%) | -72.81M (+8.32%) | -67.22M (+19.61%) | -56.20M (+161.88%) | -21.46M (-54.71%) | -47.38M (+46.69%) | -32.30M (+32.21%) | -24.43M (+12.63%) | -21.69M (+1.21%) | -21.43M (+7.63%) | -19.91M (+65.37%) | -12.04M |